Intelligent Bio Solutions Inc. (INBS) reported fiscal second quarter results with revenue growth of 48% year-over-year. For the first half of fiscal 2026, revenue surpassed USD 2 million, representing a 36% increase compared to the previous year. Reader sales more than doubled in the second quarter, rising 104% year-over-year, supporting the company’s razor-razorblade business model momentum. Gross profit margins for the first half of fiscal 2026 increased by 10 percentage points to 49%, reflecting improved operational efficiency. As of December 31, 2025, current assets stood at USD 12.17 million, including USD 9.40 million receivable related to a private placement of securities that closed on January 2, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9653200-en) on February 12, 2026, and is solely responsible for the information contained therein.